American CareSource Announces Results for Second Quarter 2013

American CareSource Announces Results for Second Quarter 2013

DALLAS--(BUSINESS WIRE)-- American CareSource Holdings (NAS: ANCI) , a leading national network of ancillary healthcare providers, today reported results for the three months ended June 30, 2013.

Net Revenue

Net revenue for the second quarter of 2013 was $6.4 million, compared with $8.2 million reported during the second quarter of 2012. For the quarter ended June 30, 2013, revenue from ACS' two significant legacy accounts declined by a combined $1.9 million, or 51 percent, as compared with the same period in 2012, due to factors described previously by the company.

Excluding the impact of our two significant legacy clients, revenue increased 3 percent, to $4.6 million in the second quarter of 2013 from $4.5 million in same period in 2012.

Claims Volumes

ACS billed 32,000 claims during the second quarter of 2013, a decrease from 42,000 claims billed during the same period last year. The lower claims volume was primarily the result of declines in claims volume from the company's two key legacy client accounts, in addition to other selected legacy accounts.

Following are claims volumes for the periods presented:

(Claim amounts in 000's) Q2 2013 Q1 2013 Q2 2012

Contribution Margin

Contribution margin for the second quarter of 2013 decreased to 9.2 percent, as compared with 12.8 percent reported during the second quarter of 2012. The decrease in contribution margin was primarily the result of the increase in provider payments as a percentage of revenue, from 74 percent in the second quarter of 2012 to 76.2 percent in the same period this year. The decline in margin on provider payments is the result of the combination of the mix of clients using our network of ancillary service providers and the mix of ancillary service categories utilized. The mix of clients and service categories shifted from those that have historically contributed higher margins as compared with the second quarter of 2012.

Contribution margin was also negatively impacted by the cost of claims administration and provider development. Those costs as a percentage of revenue increased to 10.6 percent in the second quarter of 2013 from 8.8 percent in the second quarter of 2012. The increase was the result of the decline in revenue in the second quarter of 2013 compared to the second quarter of 2012. In absolute dollars, claims administration and provider development costs decreased 6.5 percent to $678,000 in the second quarter of 2013 compared to the second quarter of the prior year. The decline was primarily the result of a decline in outsourced claims processing costs and a decline in headcount through natural attrition.

Following is a comparison of statement of operations components as a percentage of net revenue:

  Q2 2013 Q1 2013 Q2 2012
Provider payments 76.2% 76.5% 74.0%
Administrative fees4.0%4.3%4.4%
Claims administration and provider development 10.6% 9.0% 8.8%
Total cost of revenues 90.8% 89.8% 87.2%

Selling, General and Administrative Expenses (SG&A)

SG&A for the second quarter of 2013 increased to $1.9 million from $1.6 million in the same period last year. The 15 percent increase was primarily the result of a $216,000 severance charge related to the resignations of the Company's former President and former Chief Information Officer in June 2013.

SG&A was 29.3 percent of revenues in the second quarter of 2013, as compared to 20 percent in the second quarter of 2012.

Adjusted EBITDA

Adjusted EBITDA for the second quarter of 2013 was a loss of $1 million, compared to a loss of $386,000 in the prior-year period.

Adjusted EBITDA is defined as operating income or loss before interest, income taxes, depreciation and amortization and excludes the impact of non-cash stock-based compensation expense, severance charges, amortization of long-term client agreements and other non-cash charges. Adjusted EBITDA should be considered in addition to, but not in lieu of, income or loss from operations reported under generally accepted accounting principles (GAAP).

A reconciliation of adjusted EBITDA to operating income or loss is provided in the tables accompanying this release.

Financial Liquidity

Total cash and cash equivalents as of June 30, 2013, were $7.8 million, as compared with $8.9 million on March 31 and $10.7 million as of Dec. 31, 2012.

About American CareSource Holdings, Inc.

American CareSource Holdings is the first national, publicly traded ancillary care network services company. The company offers a comprehensive national network of more than 4,900 ancillary service providers at more than 34,200 sites through its subsidiary, Ancillary Care Services. ACS provides ancillary healthcare services through its network that offers cost-effective alternatives to physician and hospital-based services. These providers offer services in 31 categories including laboratories, dialysis centers, free-standing diagnostic imaging centers, infusion centers, long-term acute care centers, home-health services and non-hospital surgery centers, as well as durable medical equipment. The company's ancillary network and management provide a complete outsourced solution for a wide variety of healthcare payors and plan sponsors including self-insured employers, indemnity insurers, PPOs, HMOs, third-party administrators and both federal and local governments. For additional information, please visit


Safe Harbor Statement Under the Private Securities Litigation Reform Act of 1995:

Any statements that are not historical facts contained in this release, including with respect to the company's plans, objectives and expectations for future operations, projections of the company's future operating results or financial condition, and expectations regarding the healthcare industry and economic conditions, are forward-looking statements. Substantial risks and uncertainties could cause actual results to differ materially from those indicated by such forward-looking statements, including, but not limited to, the company's dependence upon its two largest clients and recent declines in their business, the company's inability to attract or maintain providers or clients or achieve its financial results, changes in national healthcare policy, federal or state regulation, and/or rates of reimbursement including without limitation the impact of the Patient Protection and Affordable Care Act, Health Care and Educational Affordability Reconciliation Act and medical loss ratio regulations, general economic conditions (including the recent economic downturns and increases in unemployment), lower than anticipated demand for ancillary services, pricing, market acceptance/preference, the company's ability to integrate with its clients, consolidation in the industry that affect the company's key clients, changes in the business decisions by significant clients, term expirations of contracts with significant clients, possible termination of relationship with significant clients, increased competition, decisions by service providers in the company's network to terminate their agreements with ACS, the company's inability to manage growth, implementation and performance difficulties, and other risk factors detailed from time to time in the company's periodic filings with the Securities and Exchange Commission. Except as otherwise required by law, the company undertakes no obligation to update or revise these forward-looking statements.

(amounts in thousands except per share data)
Three months endedSix months ended
June 30,June 30,
Net revenues$6,443$8,215$14,048$17,616
Cost of revenues:
Provider payments4,9126,07810,72812,873
Administrative fees258364588828
Claims administration and provider development 678  725  1,366  1,577 
Total cost of revenues 5,848  7,167  12,682  15,278 
Contribution margin5951,0481,3662,338
Selling, general and administrative expenses1,8881,6393,5923,261
Depreciation and amortization212221423440
Total operating expenses 2,100  1,860  4,015  3,701 
Loss before income taxes(1,505)(812)(2,649)(1,363)
Income tax provision 4  17  11  24 
Net loss$(1,509)$(829)$(2,660)$(1,387)
Loss per basic and diluted common share$(0.26)$(0.15)$(0.47)$(0.24)
Basic and diluted weighted average common shares outstanding 5,712  5,710  5,711  5,703 

Reconciliation of non-GAAP financial measures to reported GAAP financial measures:

Three months endedSix months ended
June 30,June 30,
Net loss$(1,509)$(829)$(2,660)$(1,387)
Income tax provision4171124
Depreciation and amortization212221423440
Other (7) (6) (15) (9)
Non-cash stock-based compensation expense76121153252
Amortization of long-term client agreement63125
Severance charges (included in selling, general and administrative expenses) 216  27  216  70 
EBITDA, as adjusted$(1,008)$(386)$(1,872)$(485)
(amounts in thousands)

June 30,

(unaudited)December 31, 2012
Current assets:
Cash and cash equivalents$7,838$10,705
Accounts receivable, net2,6152,432
Prepaid expenses and other current assets 400  296 
Total current assets10,85313,433
Property and equipment, net1,4211,593
Other assets:
Other non-current assets237238
Intangible assets, net 704  768 
TOTAL ASSETS$13,215 $16,032 
Current liabilities:
Due to service providers$2,513$3,100
Accounts payable and accrued liabilities 1,615  1,343 
Total current liabilities4,1284,443
Common stock5757
Additional paid-in capital23,00322,845
Accumulated deficit (13,973) (11,313)
 9,087  11,589 
(amounts in thousands)

Six months ended
June 30,

Cash flows from operating activities:
Net loss$(2,660)$(1,387)
Adjustments to reconcile net loss to net cash used in operations:
Non-cash stock-based compensation expense153252
Depreciation and amortization423440
Amortization of long-term client agreement125
Deferred income taxes13
Changes in operating assets and liabilities:
Accounts receivable(183)979
Prepaid expenses and other assets(104)(69)
Accounts payable and accrued liabilities272(181)
Due to service providers (587) (629
Read Full Story
Scroll to continue with content AD
  • DJI29348.1050.460.17%
    S&P 5003329.6212.810.39%
  • NIKKEI 22524041.26108.130.45%
    Hang Seng29056.42173.380.60%
  • USD (PER EUR)1.110.00000.00%
    USD (PER CHF)1.030.00020.02%
    JPY (PER USD)110.150.00000.00%
    GBP (PER USD)1.300.00000.00%
More to Explore